Literature DB >> 7956279

Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide.

M Tanabe1, M Ueda, M Endo, M Kitajima.   

Abstract

OBJECTIVE: To clarify how plasma atrial natriuretic peptide concentrations vary with the severity of acute lung injury. The influence of coexisting diseases which trigger acute lung injury was also examined.
DESIGN: Prospective study.
SETTING: Intensive care unit of a university hospital. PATIENTS: Fifty patients who had standard risk factors for acute lung injury including sepsis syndrome, major surgery, prolonged hypotension, aspiration of gastric contents, and burns. Twenty-five of these patients had acute lung injury (group 3) caused by these disorders; the remaining 25 patients had risk factors only (group 2). Ten age-matched normal volunteers were selected as controls (group 1). INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: Plasma atrial natriuretic peptide concentration was measured in these patients and compared with the severity of acute lung injury. In group 3, a significant increase in the mean plasma atrial natriuretic peptide concentration was observed (188 +/- 78 pg/mL, p < .01) compared with group 2 (54 +/- 28 pg/mL) and the age-matched control group (30 +/- 8 pg/mL). This increase was related to the onset of acute lung injury and returned to control concentrations after recovery. Plasma atrial natriuretic peptide concentrations in group 3 correlated highly with a lung injury score representing the severity of acute lung injury (r2 = .45, p < .01), but did not correlate with other cardiopulmonary variables.
CONCLUSION: The results suggest that severity of lung injury, but not other predisposing disorders, may be the key factor leading to the increase in plasma atrial natriuretic peptide concentrations observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956279

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Blood levels of atrial natriuretic peptide, endothelin, cortisol and ACTH in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.

Authors:  A Roth-Isigkeit; L Dibbelt; W Eichler; J Schumacher; P Schmucker
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

2.  Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Nobuyuki Saito; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

3.  Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.

Authors:  Kanetaka Maeshiro; Shinzo Takamori; Hiroharu Mifune; Toshihiro Matsuo; Norman Y Kimura; Junichi Honda; Kazuo Shirouzu
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

4.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10

Review 5.  Science review: natriuretic peptides in critical illness.

Authors:  Rochus Witthaut
Journal:  Crit Care       Date:  2004-06-17       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.